The National Comprehensive Cancer Network (NCCN), with the support of the NCCN Foundation and Lung Cancer Alliance, has released the NCCN Guidelines for Patients for Lung Cancer Screening, as the latest addition to the library of NCCN Guidelines for Patients, patient-friendly translations of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines).
The NCCN Guidelines for Patients: Lung Cancer Screening is dedicated to the at-risk public and is supported by Lung Cancer Alliance.
The NCCN Guidelines are developed by multidisciplinary panels of experts from NCCN Member Institutions and feature algorithms or “decision trees” that address every appropriate management option from initial work-up throughout the course of the disease. The NCCN Guidelines for Patients translate these professional guidelines in a step-by-step manner that people can use as the basis for making decisions and discussing treatment options with their physicians.
NCCN offers nine other NCCN Guidelines for Patients including breast, colon, non-small cell lung, ovarian and prostate cancers, chronic myelogenous leukemia, malignant pleural mesothelioma, melanoma and multiple myeloma. Additional NCCN Guidelines for Patients will be available throughout 2012.
The NCCN Guidelines for Patients for Lung Cancer Screening is now available free of charge at NCCN.org, NCCN.com and LungCancerAlliance.org.